Ulipristal acetate: a guide to its use in uterine fibroids
- First Online:
- Cite this article as:
- Lyseng-Williamson, K.A. & Croxtall, J.D. Drugs Ther Perspect (2012) 28: 1. doi:10.1007/BF03262118
- 64 Downloads
Oral ulipristal acetate (Esmya™), a selective progesterone-receptor modulator, is an effective and well tolerated option for the pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. It is associated with rapid control of excessive uterine bleeding and sustained reductions in uterine fibroid volume.